Home

CFR Journal

Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients

Alessandra Cuomo, Alessio Rodolico, Amalia Galdieri, Michele Russo, Giacomo Campi, Riccardo Franco, Dalila Bruno, Luisa Aran, Antonio Carannante, Umberto Attanasio, Carlo G Tocchetti, Gilda Varricchi, Valentina Mercurio

Cardiac Failure Review 2019;5(2):112–8.

Login or register to view PDF.

Read Article
Diet, the Gut Microbiome and Heart Failure

Sivadasanpillai Harikrishnan

Cardiac Failure Review 2019;5(2):119–22.

Login or register to view PDF.

Read Article
Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology

Edoardo Bertero, Pietro Ameri, Christoph Maack

Cardiac Failure Review 2019;5(2):106–11.

Login or register to view PDF.

Read Article

Webinars

Natriuretic peptides in chronic heart failure

13 Jun 2019
How to personalize NOAC for special populations and special...

08 Mar 2016
Focused Ultrasound in the Emergency Department for the Diagn...

12 Jan 2016
The Management of Heart Failure with Preserved Ejection Frac...

10 Jun 2015

Videos

Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress: Resolving dilemmas in the treatment of heart failure

Experts on the Spot: Your questions on dilemmas in the treatment of heart failure answered

Novartis Sponsored Satellite Symposium at EuroPrevent 2018 entitled:
Inflammation in Atherosclerosis: Translating Science into Practicable Solutions

© 2018 Novartis Pharma AG, CH-4002 Basel | April 2018 | GLCM/ATH/0331k